Alpha-fetoprotein assay in patients treated with low-dose oral contraceptives.
AFP has proven to be a useful marker for liver neoplasms. The authors assayed AFP plasma levels in patients taking low-dose estro- progestinics . Patients were divided into three groups on the basis of their living habits. No difference was found in any group between AFP levels before and after treatment. However, in the group of smokers using oral contraceptives AFP levels were significantly higher.